{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T23:56:21Z","timestamp":1783468581357,"version":"3.55.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T00:00:00Z","timestamp":1748390400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1162503"],"award-info":[{"award-number":["APP1162503"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000923","name":"Australian Research Council","doi-asserted-by":"publisher","award":["FT190100482"],"award-info":[{"award-number":["FT190100482"]}],"id":[{"id":"10.13039\/501100000923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000923","name":"Australian Research Council","doi-asserted-by":"publisher","award":["DE210100422"],"award-info":[{"award-number":["DE210100422"]}],"id":[{"id":"10.13039\/501100000923","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.ejphar.2025.177751","type":"journal-article","created":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T02:42:42Z","timestamp":1747968162000},"page":"177751","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["A hydrophobic loop of the spider-venom peptide Tl1a drives activity at NaV1.8"],"prefix":"10.1016","volume":"1001","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1695-1604","authenticated-orcid":false,"given":"Ashvriya","family":"Thapa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5181-1899","authenticated-orcid":false,"given":"Hue","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7137-1656","authenticated-orcid":false,"given":"Lotten","family":"Ragnarsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2846-052X","authenticated-orcid":false,"given":"Angelo","family":"Keramidas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Volker","family":"Herzig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Brinkwirth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5107-8938","authenticated-orcid":false,"given":"Jennifer R.","family":"Deuis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Vetter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2025.177751_bib1","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1021\/acs.jmedchem.1c01570","article-title":"Development of ProTx-II analogues as highly selective peptide blockers of Na(v)1.7 for the treatment of pain","volume":"65","author":"Adams","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2025.177751_bib2","doi-asserted-by":"crossref","first-page":"9041","DOI":"10.1074\/jbc.RA118.002553","article-title":"Gating modifier toxins isolated from spider venom: modulation of voltage-gated sodium channels and the role of lipid membranes","volume":"293","author":"Agwa","year":"2018","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2025.177751_bib3","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/379257a0","article-title":"A tetrodotoxin-resistant voltage-gated sodium channel expressed by sensory neurons","volume":"379","author":"Akopian","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2025.177751_bib4","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.tips.2009.12.007","article-title":"Targeting voltage sensors in sodium channels with spider toxins","volume":"31","author":"Bosmans","year":"2010","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejphar.2025.177751_bib5","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.toxicon.2006.11.029","article-title":"Sea anemone venom as a source of insecticidal peptides acting on voltage-gated na+ channels","volume":"49","author":"Bosmans","year":"2007","journal-title":"Toxicon"},{"key":"10.1016\/j.ejphar.2025.177751_bib6","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1124\/pr.57.4.4","article-title":"International union of pharmacology. XLVII. Nomenclature and structure-function relationships of voltage-gated sodium channels","volume":"57","author":"Catterall","year":"2005","journal-title":"Pharmacol. Rev."},{"issue":"5","key":"10.1016\/j.ejphar.2025.177751_bib7","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.tips.2025.02.008","article-title":"Suzetrigine for moderate to severe acute pain","volume":"46","author":"Cho","year":"2025","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejphar.2025.177751_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.113991","article-title":"A selective NaV1. 1 activator with potential for treatment of Dravet syndrome epilepsy","volume":"181","author":"Chow","year":"2020","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.177751_bib9","first-page":"1","article-title":"Pharmacological characterisation of the highly NaV1. 7 selective spider venom peptide Pn3a","volume":"7","author":"Deuis","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2025.177751_bib10","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.neuropharm.2017.04.014","article-title":"The pharmacology of voltage-gated sodium channel activators","volume":"127","author":"Deuis","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2025.177751_bib11","article-title":"The tarantula venom peptide Eo1a binds to the domain II S3-S4 extracellular loop of voltage-gated sodium channel NaV1. 8 to enhance activation","volume":"12","author":"Deuis","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.177751_bib12","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0014-5793(99)01519-7","article-title":"Two tetrodotoxin\u2010resistant sodium channels in human dorsal root ganglion neurons","volume":"462","author":"Dib-Hajj","year":"1999","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ejphar.2025.177751_bib13","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1113\/jphysiol.2003.042127","article-title":"The TTX-resistant sodium channel Nav1.8 (SNS\/PN3): Expression and correlation with membrane properties in rat nociceptive primary afferent neurons","volume":"550","author":"Djouhri","year":"2003","journal-title":"J. Physiol."},{"key":"10.1016\/j.ejphar.2025.177751_bib14","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1016\/j.bpj.2016.08.043","article-title":"Extracellular linkers completely transplant the voltage dependence from Kv1.2 ion channels to Kv2.1","volume":"111","author":"Elinder","year":"2016","journal-title":"Biophys. J."},{"key":"10.1016\/j.ejphar.2025.177751_bib15","first-page":"19444","article-title":"Gain-of-function Nav1. 8 mutations in painful neuropathy","volume":"109","author":"Faber","year":"2012"},{"key":"10.1016\/j.ejphar.2025.177751_bib16","author":"Fda","year":"2025"},{"key":"10.1016\/j.ejphar.2025.177751_bib17","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.toxicon.2018.06.077","article-title":"Dipteran toxicity assays for determining the oral insecticidal activity of venoms and toxins","volume":"150","author":"Guo","year":"2018","journal-title":"Toxicon"},{"key":"10.1016\/j.ejphar.2025.177751_bib18","doi-asserted-by":"crossref","DOI":"10.1177\/1744806919858801","article-title":"Na(v)1.7 and Na(v)1.8: role in the pathophysiology of pain","volume":"15","author":"Hameed","year":"2019","journal-title":"Mol. Pain"},{"key":"10.1016\/j.ejphar.2025.177751_bib19","volume":"119","author":"Huang","year":"2022"},{"key":"10.1016\/j.ejphar.2025.177751_bib20","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1021\/acsptsci.1c00072","article-title":"Pharmacological inhibition of the voltage-gated sodium channel Nav1. 7 alleviates chronic visceral pain in a rodent model of irritable bowel syndrome","volume":"4","author":"Jiang","year":"2021","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"10.1016\/j.ejphar.2025.177751_bib21","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","article-title":"Highly accurate protein structure prediction with AlphaFold","volume":"596","author":"Jumper","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2025.177751_bib22","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.toxicon.2008.05.020","article-title":"A rational nomenclature for naming peptide toxins from spiders and other venomous animals","volume":"52","author":"King","year":"2008","journal-title":"Toxicon"},{"key":"10.1016\/j.ejphar.2025.177751_bib23","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.toxicon.2012.04.337","article-title":"Spider-venom peptides that target voltage-gated sodium channels: pharmacological tools and potential therapeutic leads","volume":"60","author":"Klint","year":"2012","journal-title":"Toxicon"},{"key":"10.1016\/j.ejphar.2025.177751_bib24","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1021\/acsptsci.0c00002","article-title":"Mapping the molecular surface of the analgesic NaV1.7-Selective peptide Pn3a reveals residues essential for membrane and channel interactions","volume":"3","author":"Mueller","year":"2020","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"10.1016\/j.ejphar.2025.177751_bib25","doi-asserted-by":"crossref","first-page":"15353","DOI":"10.1021\/bi981255g","article-title":"Selective peptide antagonist of the class E calcium channel from the venom of the tarantula Hysterocrates gigas","volume":"37","author":"Newcomb","year":"1998","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejphar.2025.177751_bib26","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.toxicon.2004.02.006","article-title":"Structure and function of \u03b4-atracotoxins: lethal neurotoxins targeting the voltage-gated sodium channel","volume":"43","author":"Nicholson","year":"2004","journal-title":"Toxicon"},{"key":"10.1016\/j.ejphar.2025.177751_bib27","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/312121a0","article-title":"Primary structure of Electrophorus electricus sodium channel deduced from cDNA sequence","volume":"312","author":"Noda","year":"1984","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2025.177751_bib28","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/nature17976","article-title":"Selective spider toxins reveal a role for the Nav1.1 channel in mechanical pain","volume":"534","author":"Osteen","year":"2016","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.ejphar.2025.177751_bib29","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1007\/s40122-024-00697-0","article-title":"Pharmacology and mechanism of action of suzetrigine, a potent and selective NaV1.8 pain signal inhibitor for the treatment of moderate to severe pain","volume":"14","author":"Osteen","year":"2025","journal-title":"Pain and Therapy"},{"key":"10.1016\/j.ejphar.2025.177751_bib30","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/nature11077","article-title":"Crystal structure of a voltage-gated sodium channel in two potentially inactivated states","volume":"486","author":"Payandeh","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2025.177751_bib31","doi-asserted-by":"crossref","first-page":"5953","DOI":"10.1074\/jbc.271.11.5953","article-title":"Structure and function of a novel voltage-gated, tetrodotoxin-resistant sodium channel specific to sensory neurons (\u2217)","volume":"271","author":"Sangameswaran","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2025.177751_bib32","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/0896-6273(95)90184-1","article-title":"An inhibitor of the Kv2. 1 potassium channel isolated from the venom of a Chilean tarantula","volume":"15","author":"Swartz","year":"1995","journal-title":"Neuron"},{"key":"10.1016\/j.ejphar.2025.177751_bib33","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.molcel.2020.10.039","article-title":"Structural basis for high-affinity trapping of the NaV1. 7 channel in its resting state by tarantula toxin","volume":"81","author":"Wisedchaisri","year":"2021","journal-title":"Molecular cell"},{"key":"10.1016\/j.ejphar.2025.177751_bib34","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.cell.2018.12.018","article-title":"Structural basis of Nav1. 7 inhibition by a gating-modifier spider toxin","volume":"176","author":"Xu","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.ejphar.2025.177751_bib35","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines8020037","article-title":"Addition of K22 converts spider venom peptide Pme2a from an activator to an inhibitor of NaV1.7","volume":"8","author":"Yin","year":"2020","journal-title":"Biomedicines"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299925005059?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299925005059?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T04:28:42Z","timestamp":1762144122000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299925005059"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":35,"alternative-id":["S0014299925005059"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2025.177751","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A hydrophobic loop of the spider-venom peptide Tl1a drives activity at NaV1.8","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2025.177751","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"177751"}}